Latest News

09.25.20

Novavax Begins Phase 3 Coronavirus Vaccine Trial in UK

Source: FirstWord

09.25.20

FDA Grants Orphan Drug Designation for Neurophth Therapeutics’ Gene Therapy for LHON

Source: Neurophth Therapeutics

09.25.20

Micro Labs USA Launches Two New Glaucoma Drugs

Source: Micro Labs USA

09.25.20

Trump Signs Executive Orders on Preexisting Condition Protections, Surprise Billing

Source: FierceHealthcare

09.25.20

FDA Approves Bausch + Lomb Alaway Preservative Free OTC Drops

Source: Bausch Health

09.24.20

House Government Funding Bill Gives Providers Relief on Medicare Advance Payments

Source: FierceHealthcare

09.24.20

How is Night Vision Maintained During Retinal Disease? Research Provides New Insight

Source: John A. Moran Eye Center

09.24.20

Optimo Medical Gets Support by Innosuisse to Enter the US Market

Source: Optimo Medical

09.24.20

Bausch Health Announces Vyzulta Now Approved in Seven Countries; Expanded Coverage in Canada

Source: Bausch Health

09.24.20

UK to Run Challenge Trials for COVID-19 Vaccines: Report

Source: FirstWord

09.24.20

Whitney Hauser, OD, FAAO, Joins Novartis Ophthalmics

Source: Novartis

09.24.20

US Eye Network Expands into Southeastern US through Partnership with Carolina Eyecare Physicians

Source: US Eye

09.24.20

Fight for Sight and Prevent Blindness Announce Recipient of the 2020 Joanne Angle Public Health Award

Source: Prevent Blindness

09.24.20

Aerie Pharmaceuticals Announces Interim 90-Day Topline Data From Its 6-Month Mercury 3 Clinical Trial in Europe

Source: Aerie Pharmaceuticals

09.23.20

Nicox Selects 0.1% NCX 470 Dose in Adaptive Stage of Mont Blanc Phase 3 Glaucoma Trial

Source: Nicox

09.23.20

KKR to Acquire 1-800 Contacts from AEA Investors

Source: 1-800 Contacts

View more stories